(isatuximab) Phase 3 trial met primary endpoint of progression free survival in patie | IMGN Message Board Posts


IMGN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  57278 of 57658  at  12/7/2023 2:29:18 PM  by

GaryM


 In response to msg 57276 by  wal187lco
view thread

Re: (isatuximab) Phase 3 trial met primary endpoint of progression free survival in patie

They'd have no problem going substantially higher if the offer wasn't a cash only offer.  With new stock added to the possibilities they could easily add billions, even tens of billions if they wished.
 
Gary 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 0  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board




Financial Market Data provided by
.
Loading...